Report overview
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.
This report aims to provide a comprehensive presentation of the global market for Contraceptives Drugs and Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives Drugs and Devices. This report contains market size and forecasts of Contraceptives Drugs and Devices in global, including the following market information:
Global Contraceptives Drugs and Devices Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Contraceptives Drugs and Devices Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Contraceptives Drugs and Devices companies in 2022 (%)
The global Contraceptives Drugs and Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Contraceptives Drugs and Devices include Teva Pharmaceutical Industries Ltd, Church & Dwight Co. Inc, Reckitt Benckiser Plc, Pfizer, Inc, Bayer AG, Mayer Laboratories, Inc, The Female Health Company, Cooper Surgical, Inc and Allergan plc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Contraceptives Drugs and Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Contraceptives Drugs and Devices Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Contraceptives Drugs and Devices Market Segment Percentages, by Type, 2022 (%)
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Global Contraceptives Drugs and Devices Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Contraceptives Drugs and Devices Market Segment Percentages, by Application, 2022 (%)
Female
Male
Global Contraceptives Drugs and Devices Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Contraceptives Drugs and Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Contraceptives Drugs and Devices revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Contraceptives Drugs and Devices revenues share in global market, 2022 (%)
Key companies Contraceptives Drugs and Devices sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Contraceptives Drugs and Devices sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer, Inc
Bayer AG
Mayer Laboratories, Inc
The Female Health Company
Cooper Surgical, Inc
Allergan plc
Cipla Limited
Merck & Co. Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Contraceptives Drugs and Devices, market overview.
Chapter 2: Global Contraceptives Drugs and Devices market size in revenue and volume.
Chapter 3: Detailed analysis of Contraceptives Drugs and Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Contraceptives Drugs and Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Contraceptives Drugs and Devices capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.